Clinical Trial Update: A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

View source ↗

Summary

A multicenter clinical trial in China is evaluating a urine DNA test for bladder cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Bladder Stone
• Cystitis
• Urothelial Carcinoma

Snippet

Sponsor: Creative Biosciences (Guangzhou) Co., Ltd. | Conditions: Bladder Cancer, Urocystitis | Status: RECRUITING